FujiLAM Prospective Evaluation Trial

CompletedOBSERVATIONAL
Enrollment

1,731

Participants

Timeline

Start Date

December 13, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Diagnosis of Tuberculosis in People Living With HIV
Interventions
DEVICE

Fujifilm SILVAMP TB LAM

Fujifilm SILVAMP TB LAM detects the presence of lipoarabinomannan (LAM) in urine with a visually read lateral flow test that uses silver amplification.

Trial Locations (7)

7925

CIDRI-Africa University of Cape Town, Cape Town

34620

Centre for Infectious Disease Research in Zambia, Lusaka

Box 30096

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre

Box 78 373

Ifakara Health Institute, Dar es Salaam

Unknown

The HIV Netherlands Australia Thailand Research collaboration, Bangkok

Viet Tiep Hospital, Haiphong

Box 22418

Infectious Diseases Institute, Kampala

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Centre for Infectious Disease Research in Zambia

OTHER

collaborator

Infectious Diseases Institute, Uganda

OTHER

collaborator

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

OTHER

collaborator

Swiss Tropical & Public Health Institute

OTHER

collaborator

Ifakara Health Institute

OTHER

collaborator

University of Cape Town

OTHER

collaborator

Viet Tiep Hospital

OTHER

collaborator

National Tuberculosis Control Programme

UNKNOWN

collaborator

Fujifilm

INDUSTRY

collaborator

Omega Diagnostics

UNKNOWN

collaborator

Tuberculosis and Lung Disease Hospital in Hai Phong

UNKNOWN

collaborator

The HIV Netherlands Australia Thailand Research Collaboration

OTHER

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER